paclitaxel has been researched along with Thromboembolism, Venous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Daiku, K; Fujita, M; Fukutake, N; Higashi, S; Hiraga, E; Hirao, T; Ikezawa, K; Kai, Y; Kawamoto, Y; Maeda, S; Nakabori, T; Ohkawa, K; Takada, R; Uehara, H; Urabe, M; Yamai, T | 1 |
| Itoh, H; Nakahara, R; Sato, Y; Suzuki, K; Tanaka, R; Tatsuta, R | 1 |
| Ay, C; Barth, DA; Djanani, A; Fandler-Höfler, S; Gantschnigg, A; Gary, T; Gerger, A; Greil, R; Gressenberger, P; Hatzl, S; Horvath, L; Jost, PJ; Moik, F; Pichler, M; Posch, F; Renneberg, F; Riedl, JM; Schlick, K; Schwarzenbacher, E; Stotz, M | 1 |
| Gwynne, SH; Quinton, AE; Yim, KL | 1 |
| Cheng, H; Liu, X; Yang, Z; Zhang, G; Zhang, W | 1 |
| Aminossadati, B; duBois, A; Fotopoulou, C; Karavas, AN; Pfisterer, J; Schmalfeldt, B; Sehouli, J; Trappe, R | 1 |
6 other study(ies) available for paclitaxel and Thromboembolism, Venous
| Article | Year |
|---|---|
Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Early Detection of Cancer; Gemcitabine; Humans; Paclitaxel; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Venous Thromboembolism | 2022 |
Venous thromboembolisms and rheology in ovarian cancer patients after postoperative adjuvant paclitaxel and carboplatin therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Fibrin Fibrinogen Degradation Products; Humans; Incidence; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Rheology; Risk Factors; Venous Thromboembolism | 2020 |
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Venous Thromboembolism | 2022 |
Nab-paclitaxel in combination with gemcitabine for the treatment of metastatic pancreas cancer: the South Wales experience.
Topics: Adult; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Treatment Outcome; United Kingdom; Venous Thromboembolism | 2018 |
Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.
Topics: Age Factors; Aged; Anticoagulants; Carboplatin; China; Female; Humans; Intraoperative Care; Middle Aged; Operative Time; Ovarian Neoplasms; Paclitaxel; Platelet Count; Postoperative Care; Pulmonary Embolism; Retrospective Studies; Risk Factors; Tumor Burden; Venous Thromboembolism | 2018 |
Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Germany; Humans; Incidence; Kaplan-Meier Estimate; Logistic Models; Middle Aged; Multicenter Studies as Topic; Ovarian Neoplasms; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Venous Thromboembolism | 2008 |